Level 3 Boardrooms, Hudson Institute
Presented by Professor Patrick Tan, Duke NUS Medical School, Singapore
Dr. Patrick Tan holds a joint appointment as Professor at the Duke-NUS Medical School and Deputy Executive Director of the Biomedical Research Council (Agency for Science, Technology, and Research). He directs PRISM, the SingHealth/DukeNUS Precision Medicine Institute. He received his B.A. (summa cum laude) from Harvard University and MD PhD degree from Stanford University, where he received the Charles Yanofsky prize for Most Outstanding
Graduate Thesis in Physics, Biology or Chemistry. Other honours include the President’s Scholarship, Loke Cheng Kim scholarship, Young Scientist Award (A-STAR), Singapore Youth Award (twice), Singhealth Investigator Excellence Award, Han-Mo Koo Memorial Lectureship (Van Andel Research Institute,
USA), Swee Liew Wadsworth Lectureship (NUS), Chen New Investigator Award from the Human Genome Organization (HUGO), President’s Science Award, and Japan Cancer Association International Award. He is an elected member of
the American Society for Clinical Investigation (ASCI), International Gastric Cancer Association (Board Member), and a member of the Bioethics Advisory Committee (BAC). He coleads the biliary tract cancer project of the International
Cancer Genome Consortium (ICGC).
No comments:
Post a Comment